Abstract Sunitinib is an orally available inhibitor of multiple tyrosine-kinase receptors approved for the treatment of advanced clear-cell renal cell carcinoma (ccRCC), a disease which has habitually had a very poor patient survival rate. Although it has become themost widely used drug for this disease, it remains not completely clear the best treatment strategy with these agent. The aim of this review is to highlight the most recent and interesting aspects of the research on treatment of advanced ccRCC with sunitinib and eventually determine alternative treatment schedule to reduce the incidence of side effects; we also wanted to review recent biomarkers able to predict response to therapy and also to point out the mechanism of acquired resistance to this drug.

Recent Aspects of Sunitinib Therapy in Patients with Metastatic Clear-Cell Renal Cell Carcinoma: a Systematic Review of the Literature / Minardi, D.; Quaresima, L.; Santoni, M.; Bianconi, M.; Scartozzi, M.; Cascinu, Stefano; Muzzonigro, G.. - In: CURRENT UROLOGY REPORTS. - ISSN 1527-2737. - 16:3(2015), pp. 1-7. [10.1007/s11934-014-0478-2]

Recent Aspects of Sunitinib Therapy in Patients with Metastatic Clear-Cell Renal Cell Carcinoma: a Systematic Review of the Literature

CASCINU, Stefano;
2015

Abstract

Abstract Sunitinib is an orally available inhibitor of multiple tyrosine-kinase receptors approved for the treatment of advanced clear-cell renal cell carcinoma (ccRCC), a disease which has habitually had a very poor patient survival rate. Although it has become themost widely used drug for this disease, it remains not completely clear the best treatment strategy with these agent. The aim of this review is to highlight the most recent and interesting aspects of the research on treatment of advanced ccRCC with sunitinib and eventually determine alternative treatment schedule to reduce the incidence of side effects; we also wanted to review recent biomarkers able to predict response to therapy and also to point out the mechanism of acquired resistance to this drug.
28-gen-2015
16
3
1
7
Recent Aspects of Sunitinib Therapy in Patients with Metastatic Clear-Cell Renal Cell Carcinoma: a Systematic Review of the Literature / Minardi, D.; Quaresima, L.; Santoni, M.; Bianconi, M.; Scartozzi, M.; Cascinu, Stefano; Muzzonigro, G.. - In: CURRENT UROLOGY REPORTS. - ISSN 1527-2737. - 16:3(2015), pp. 1-7. [10.1007/s11934-014-0478-2]
Minardi, D.; Quaresima, L.; Santoni, M.; Bianconi, M.; Scartozzi, M.; Cascinu, Stefano; Muzzonigro, G.
File in questo prodotto:
File Dimensione Formato  
HANDLE 11380 1079152.pdf

non disponibili

Tipologia: Versione dell'editore (versione pubblicata)
Dimensione 811.94 kB
Formato Adobe PDF
811.94 kB Adobe PDF   Visualizza/Apri   Richiedi una copia
Pubblicazioni consigliate

Caricamento pubblicazioni consigliate

Licenza Creative Commons
I metadati presenti in IRIS UNIMORE sono rilasciati con licenza Creative Commons CC0 1.0 Universal, mentre i file delle pubblicazioni sono rilasciati con licenza Attribuzione 4.0 Internazionale (CC BY 4.0), salvo diversa indicazione.
In caso di violazione di copyright, contattare Supporto Iris

Utilizza questo identificativo per citare o creare un link a questo documento: http://hdl.handle.net/11380/1079152
Citazioni
  • ???jsp.display-item.citation.pmc??? 6
  • Scopus 11
  • ???jsp.display-item.citation.isi??? 11
social impact